China

Latest News and Resources

CDMO News

Altruist Biologics Secures NMPA Priority Review for Localized Biologic Drug Manufacturing

30 October 2026

CDMO News

Asymchem Completes First USFDA Pre-Approval Inspection at Tianjin TIDES Facility

30 October 2026

CDMO News

ProBio Completes NMPA Pre-Approval Inspection at Nanjing Biologics Facility

26 October 2026

CDMO News

ESTEVE CDMO Invests More Than $80 Million in New China Manufacturing Site

26 October 2026

CDMO News

Altruist Biologics Suzhou Facility Passes EMA GMP Inspection

25 September 2026

Policy Briefing

China Aims for 25% of Global First-in-Class Drugs by 2030

21 September 2026

CDMO News

WuXi XDC Licenses WuXiTecan-2 ADC Technology to Ona Therapeutics

18 September 2026

CDMO News

ProBio and Kun Tuo Partner on Integrated CDMO-CRO Solutions in China

17 September 2026

CDMO News

Novo Holdings Makes Strategic Investment in ForYou Medical

14 September 2026

CDMO News

Transcenta Therapeutics Signs Technology Licensing Deal With WuXi Biologics

10 September 2026